azacycloheptane-2,2-diphosphonate has been researched along with Arteriosclerosis in 2 studies
*Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aspen, AJ; Kramsch, DM; Rozler, LJ | 1 |
| Kramsch, DM | 1 |
2 other study(ies) available for azacycloheptane-2,2-diphosphonate and Arteriosclerosis
| Article | Year |
|---|---|
Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcium; Cholesterol; Diet, Atherogenic; Diphosphonates; Etidronic Acid; Lanthanum; Macaca fascicularis; Pamidronate | 1981 |
Calcium antagonists and atherosclerosis.
Topics: Animals; Arteriosclerosis; Calcium; Cholesterol; Collagen; Diet, Atherogenic; Diphosphonates; Elastin; Etidronic Acid; Humans; Lanthanum; Macaca fascicularis; Male; Muscle, Smooth, Vascular; Piperazines; Rabbits | 1985 |